GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $887,855. The enterprise value is -$4.01 million.

Market Cap	887,855
Enterprise Value	-4.01M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, before market open.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 525,358 shares outstanding.

Current Share Class	525,358
Shares Outstanding	525,358
Shares Change (YoY)	n/a
Shares Change (QoQ)	+164.06%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	2.48%
Float	524,755

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.24
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.03.

Current Ratio	3.43
Quick Ratio	3.07
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -382.52% and return on invested capital (ROIC) is -232.68%.

Return on Equity (ROE)	-382.52%
Return on Assets (ROA)	-118.39%
Return on Invested Capital (ROIC)	-232.68%
Return on Capital Employed (ROCE)	-200.71%
Revenue Per Employee	n/a
Profits Per Employee	-$2.53M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.29% in the last 52 weeks. The beta is -2.38, so GRI Bio's price volatility has been lower than the market average.

Beta (5Y)	-2.38
52-Week Price Change	-98.29%
50-Day Moving Average	5.17
200-Day Moving Average	10.63
Relative Strength Index (RSI)	31.24
Average Volume (20 Days)	1,040,057

Short Selling Information

The latest short interest is 65,886, so 12.54% of the outstanding shares have been sold short.

Short Interest	65,886
Short Previous Month	19,433
Short % of Shares Out	12.54%
Short % of Float	12.56%
Short Ratio (days to cover)	2.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.24M
Pretax Income	-12.77M
Net Income	-10.12M
EBITDA	-8.23M
EBIT	-8.24M
Earnings Per Share (EPS)	-$55.21

Full Income Statement

Balance Sheet

The company has $5.03 million in cash and $119,000 in debt, giving a net cash position of $4.91 million or $9.34 per share.

Cash & Cash Equivalents	5.03M
Total Debt	119,000
Net Cash	4.91M
Net Cash Per Share	$9.34
Equity (Book Value)	4.03M
Book Value Per Share	7.67
Working Capital	3.98M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.61M
Capital Expenditures	n/a
Free Cash Flow	-8.61M
FCF Per Share	-$16.39

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,126.27%
FCF Yield	-958.52%

Analyst Forecast

The average price target for GRI Bio is $115.50, which is 6,734.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$115.50
Price Target Difference	6,734.32%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-44.28%

Stock Forecasts

Stock Splits

The last stock split was on February 24, 2025. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date	Feb 24, 2025
Split Type	Reverse
Split Ratio	0.0588235:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2